Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • My alerts
  • Log in
  • Log out
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: Stage-Specific Requirement of IL-18 for Antiviral NK Cell Expansion

Sharline Madera and Joseph C. Sun
J Immunol February 15, 2015, 194 (4) 1408-1412; DOI: https://doi.org/10.4049/jimmunol.1402001
Sharline Madera
Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph C. Sun
Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Abstract

Although NK cells are considered part of the innate immune system, recent studies have demonstrated the ability of Ag-experienced NK cells to become long-lived and contribute to potent recall responses similar to T and B cells. The precise signals that promote the generation of a long-lived NK cell response are largely undefined. In this article, we demonstrate that NK cells require IL-18 signaling to generate a robust primary response during mouse CMV (MCMV) infection but do not require this signal for memory cell maintenance or recall responses. IL-12 signaling and STAT4 in activated NK cells increased the expression of the adaptor protein MyD88, which mediates signaling downstream of the IL-18 and IL-1 receptors. During MCMV infection, NK cells required MyD88, but not IL-1R, for optimal expansion. Thus, an IL-18–MyD88 signaling axis facilitates the prolific expansion of NK cells in response to primary viral infection, but not recall responses.

Introduction

Natural killer cells play a significant role in the control of infected, stressed, or transformed cells that may be detrimental to the host. Recent studies in mice and humans have demonstrated that NK cells possess adaptive immune qualities (1). In mice infected with mouse CMV (MCMV), Ly49H+ NK cells activated by the viral glycoprotein m157 undergo extensive proliferation and contract, resulting in the formation of a small pool of long-lived memory NK cells that can be recalled, and exhibit heightened effector function (1).

Proinflammatory cytokines strongly influence the NK cell response against MCMV infection (2). Although previous work has described the effect of proinflammatory cytokines on the general activation of NK cells during MCMV infection (2), their role in driving clonal-like expansion and memory in Ag-specific NK cells is largely unknown. We previously implicated IL-12, its signaling molecule STAT4, and the downstream transcription factor Zbtb32 as crucial signals in the generation of robust effector and memory NK cell responses against MCMV infection (3, 4). IL-18 has been suggested to “prime” resting NK cells for maximum IFN-γ production after ex vivo stimulation (5), and synergize with IL-12 during NK cell activation (6). Although IL-18 is produced early during MCMV infection (7), it is not known how IL-18 signals influence the virus-specific Ly49H+ NK cell response. In this study, we investigate the direct effects of IL-18 signaling on primary and recall NK cell responses to MCMV infection.

Materials and Methods

Mice and infections

All mice used in this study were bred and maintained at Memorial Sloan-Kettering Cancer Center in accordance with Institutional Animal Care and Use Committee guidelines. Mixed bone marrow chimeric mice were generated, and adoptive transfer studies and viral infections were performed as previously described (8).

Flow cytometry and cell sorting

FcRs were blocked with 2.4G2 mAb before staining with the indicated surface or intracellular Abs (BD, Biolegend, or eBioscience). Flow cytometry was performed on an LSR II (BD). Cell sorting was performed on an Aria II cytometer (BD). All data were analyzed with FlowJo software (Tree Star). NK cell enrichment and adoptive transfers were performed as previously described (3).

Quantitative RT-PCR and chromatin immunoprecipitation

Quantitative RT-PCR (qRT-PCR) and chromatin immunoprecipitation (ChIP) were performed as previously described (4). The following qRT-PCR primers were used: Myd88, Forward [For]: 5′-CACCTGTGTCTGGTCCATT-3′, Reverse [Rev]: 5′-AGGCTGAGTGCAAACTTG-3′; Actb, For: 5′-TGCGTGACATCAAAGAGAAG-3′, Rev: 5′-CGGATGTCAACGTCACACTT-3′. The following quantitative PCR primers were used for ChIP studies: Myd88 promoter, For: 5′-AAGTAGGAAACTCCACAGGCGAGC-3′, Rev: 5′-TTCAAGAACAGCGATAGGCGGC-3′; Gene desert 50 kB upstream of Foxp3, For: 5′-TAGCCAGAAGCTGGAAAGAAGCCA-3′, Rev: 5′-TGATACCCTCCAGGTCCAACCATT-3′; Zpf42 promoter, For: 5′-AGAGGGCGGTGTGTACTGTGGTG-3′, Rev: 5′-CTTCTTCTTGCACCCGGCTTGAG-3′; Utf1 promoter, For: 5′-AGTCGTTGAATACCGCGTTGCTG-3′, Rev: 5′-CTGTTGAGATGTCGCCCAAGTGC-3′; Ifng promoter, For: 5′-GCTCTGTGGATGAGAAAT-3′, Rev: 5′-GCTCTGTGGATGAGAAAT-3′.

Ex vivo stimulation of NK cells

Purified NK cells were stimulated for 4 (memory cells) or 18 h (for ChIP), as previously described (4). Negative and positive controls include NK cells incubated with media only, or with PMA (50 ng/ml) and ionomycin (1 μg/ml), respectively.

Statistical methods

All graphs depict mean ± SEM. Two-tailed paired Student t test was used to derive statistical differences. A p value <0.05 was considered significant. Plots and statistical analyses were produced in GraphPad Prism.

Results and Discussion

Cell-intrinsic IL-18 signaling required for the primary expansion of virus-specific NK cells

Although IL-18 has previously been shown to activate NK cells during viral infection, these studies involve directly infecting IL-18– and IL-18R–deficient mice (7, 9). Therefore, to address whether IL-18 influences NK cell responses in a cell-intrinsic manner, we adoptively transferred equal numbers of wild-type (WT) and Il18r1−/− NK cells into Ly49h−/− mice, which harbor normal numbers of NK cells but are incapable of recognizing the MCMV-derived m157 protein (3, 8). Postinfection (PI) with MCMV, WT NK cells preferentially expanded during the first week of infection and were higher in frequency than Il18r1−/− NK cells at day 7 PI (Supplemental Fig. 1A) and at later time points (Fig. 1A). Consistent with the adoptive transfer experiment, we observed a similar expansion defect by Il18r1−/− Ly49H+ NK cells in WT:Il18r1−/− mixed bone marrow chimeric mice infected with MCMV (Fig. 1B and Supplemental Figure 1B). Together, these studies confirm a cell-intrinsic requirement for IL-18 signaling in the antiviral NK cell response.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

IL-18R–deficient NK cells mount a defective response to viral infection. (A) WT and Il18r1−/− NK cells were cotransferred into Ly49h−/− mice and infected with MCMV. The relative ratio of populations is shown for each time point compared with day 0. (B) Mixed WT:Il18r1−/− chimeric mice were infected with MCMV, and the relative ratio of Ly49H+ NK cells are shown for day 7 PI compared with uninfected. (C) Percentages of cotransferred WT and Il18−/− Ly49H+ NK cells are shown during MCMV infection. (D) Percentages of cotransferred WT and Il18r1−/− Ly49H+ NK cells are shown postinfection with MCMV, MCMV-Δm157, VSV-m157, or VSV-Ova. (E) WT and Il18r1−/− NK cells were cotransferred into Rag2−/− × Il2rg−/− mice, and percentages of transferred Ly49H+ NK cells within the total cell population are shown. Data are mean ± SEM representative of at least four independent experiments with at least n = 3 biological replicates per condition. *p < 0.05, paired Student t test. ns, not significant.

IL-18 has been suggested to enhance IL-12–induced effector functions of NK cells such as IFN-γ production (5, 6). To determine whether IL-18 might also “prime” NK cells for MCMV-driven expansion, we isolated resting NK cells from Il18−/− mice and cotransferred them with equal numbers of WT NK cells into Ly49h−/− hosts. Post MCMV infection, WT and Il18−/− Ly49H+ NK cells exhibited comparable expansion and memory cell formation (Fig. 1C), indicating that previous exposure to IL-18 during development or homeostasis was not required for normal expansion in response to viral challenge as long as IL-18 is present during infection.

To determine whether the effect of IL-18 signaling was limited to Ag-specific NK cell responses, we used MCMV and VSV viruses engineered to lack or express m157, respectively. After adoptive transfer of WT and Il18r1−/− NK cells into Ly49h−/− hosts, we observed that in contrast with MCMV, infection with MCMV lacking m157 (MCMV-Δm157) elicited an equivalent (albeit modest) expansion of both WT and Il18r1−/− NK cell populations (Fig. 1D), indicating that IL-18 signaling is not required for the low-level proliferation of “bystander” NK cells responding to viral infection. Consistent with this observation, infection with VSV-m157, but not with VSV-Ova, elicited a preferential Ag-specific expansion of WT NK cells over Il18r1−/− NK cells (Fig. 1D). We next investigated whether IL-18 was required for NK cells to undergo homeostatic proliferation. We found that WT and Il18r1−/− NK cells proliferated similarly when transferred into Rag2−/− × Il2rg−/− mice, generating comparable long-lived populations >4 wk later (Fig. 1E), demonstrating IL-18 signaling is not required for NK cells to proliferate in response to common γ-chain cytokines. Altogether, these data suggest that IL-18 signaling directly regulates Ag-driven expansion of NK cells during viral infection, but not during bystander or homeostatic expansion.

IL-18 signaling is necessary for optimal IFN-γ production and maturation of NK cells during infection

Because IL-18 is required for optimal proliferation of NK cells during viral infection, we investigated additional NK cell effector functions that may be compromised in the absence of IL-18 signaling. At day 1.5 PI, we observed that Il18r1−/− NK cells exhibited a defect in IFN-γ production, but not granzyme B (Fig. 2A), consistent with a previous report (7). Although both NK cell populations became similarly activated at days 1.5 and 7 PI (Supplemental Fig. 1C, 1D), WT NK cells were found to be more mature, as measured by CD27 and CD11b staining, compared with Il18r1−/− cells (Fig. 2B), suggesting IL-18 may have a role in promoting the maturation of activated NK cells.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

IL-18 is necessary for optimal NK cell maturation and IFN-γ production post MCMV infection. (A) Mixed WT:Il18r1−/− chimeric mice were infected with MCMV, and amount of IFN-γ and granzyme B in NK cells at day 1.5 PI are shown. (B) WT and Il18r1−/− NK cells were cotransferred into Ly49h−/− mice and infected with MCMV. CD27 and CD11b staining is shown for WT and Il18r1−/− Ly49H+ NK cells at day 7 PI. (C) Equal numbers of purified effector WT and Il18r1−/− NK cells (at day 7 PI) were cotransferred into a naive Ly49h−/− host. Percentages of Ly49H+ NK cells are shown. Data are mean ± SEM representative of at least three independent experiments with at least n = 3 biological replicates per condition. *p < 0.05, paired Student t test. ns, not significant.

Adoptive cotransfer and bone marrow chimeric studies revealed an expansion defect in the Il18r1−/− NK cell response to MCMV infection, which could be a consequence of decreased proliferation or increased apoptosis of Il18r1−/− NK cells relative to WT NK cells. We were not able to detect differences in BrdU incorporation, Ki67 staining, or CFSE dilution by WT and Il18r1−/− NK cells in MCMV-infected bone marrow chimeric mice (data not shown), consistent with a prior study (10). In addition, FLICA incorporation studies did not reveal any differences in pan-caspase activity between Il18r1−/− and WT NK cells on day 7 PI (Supplemental Fig. 1E), suggesting that Il18r1−/− NK cells were not more susceptible to apoptosis. Lastly, when WT and Il18r1−/− effector NK cells were sorted from MCMV-infected hosts on day 7 PI, and equal numbers cotransferred into naive recipients, the two populations contracted at similar rates (Fig. 2C), indicating that Il18r1−/− NK cells are not undergoing increased cell death at later time points and that IL-18 signaling does not regulate the contraction phase or maintenance of memory NK cells.

Antiviral NK cell response depends on MyD88, but not the IL-1R

Because the IL-18R requires the adapter molecule MyD88 for downstream signaling (11), we investigated the contribution of MyD88 to the NK cell response to MCMV infection. WT:Myd88−/− mixed bone marrow chimeric mice were generated and both NK cell populations reconstituted similarly (data not shown). Post MCMV infection, Myd88−/− Ly49H+ NK cells exhibited a cell-intrinsic expansion defect compared with WT NK cells (Fig. 3A), similar to Il18r1−/− NK cells (Fig. 1C). In addition, fewer Myd88−/− NK cells produced IFN-γ after MCMV infection despite comparable upregulation of CD69 (Fig. 3B). Similar to Il18r1−/− NK cells, Myd88−/− NK cells failed to mature as efficiently as WT NK cells at day 7 PI (Fig. 3C). When equal numbers of WT and Myd88−/− NK cells were transferred into Ly49h−/− hosts followed by infection with MCMV, we observed preferential expansion and memory cell formation of the WT NK cells compared with Myd88−/− NK cells (Fig. 3D). The IL-1R, which is expressed by NK cells, is also known to use MyD88 for signaling (11); however, unlike Il18r1−/− or Myd88−/− NK cells, Il1r−/− NK cells expanded comparably with WT NK cells at day 7 PI (Fig. 3E) and showed similar effector function and phenotype as WT NK cells at days 1.5 and 7 PI (Supplemental Fig. 2A–C). These findings support a mechanism for IL-18 signaling on NK cells through a MyD88-dependent signaling axis.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

MyD88-deficient NK cells exhibit defective proliferation during MCMV infection. (A) WT:Myd88−/− chimeric mice were infected with MCMV, and percentages of splenic NK cells are shown for uninfected and day 7 PI. (B) CD69 and IFN-γ are shown for WT and Myd88−/− NK cells (compared with uninfected mice) at day 1.5 PI. (C) CD27 and CD11b staining are shown for WT and Il18r1−/− Ly49H+ NK cells at day 7 PI. (D) Percentages of cotransferred WT (CD45.1) and MyD88−/− (CD45.2) Ly49H+ NK cells are shown post MCMV infection. (E) Percentages of cotransferred WT and Il1r−/− Ly49H+ NK cells are shown during MCMV infection. Data are mean ± SEM representative of three independent experiments with at least n = 3 biological replicates per condition. *p < 0.05, paired Student t test. ns, not significant.

IL-12 signaling and STAT4 increase expression of MyD88 in activated NK cells

During MCMV infection, we observed an increase in Myd88 expression in sorted NK cells by microarray and qRT-PCR (Fig. 4A, data not shown). Given the important early role of IL-12 in activating NK cells, and a report that proinflammatory cytokines induce IL-18 signaling components in human NK cells (12), we investigated whether IL-12 directly influences the expression of the IL-18 signaling machinery. Overnight stimulation of sorted NK cells with IL-12 and IL-18 also showed an increase in the expression of Myd88 by qRT-PCR (Fig. 4B). STAT4 is a transcription factor that mediates signals downstream from the IL-12R (13), and analysis of the Myd88 promoter revealed one putative STAT4 binding site upstream of the transcriptional start site (Fig. 4C). STAT4 ChIP followed by quantitative PCR identified a significant enrichment of STAT4 binding directly upstream of the Myd88 transcriptional start site (Fig. 4D). This increase in STAT4 binding was dependent on IL-12 stimulation, suggesting Myd88 is a target gene of IL-12 signaling. Finally, we compared the expression of Myd88 in WT and Stat4−/− NK cells during MCMV infection. Activated Stat4−/− NK cells exhibited lower levels of Myd88 expression compared with WT NK cells. Altogether, these data indicate that IL-12 signaling acts through STAT4 to increase the expression of Myd88, identifying a novel role for IL-12 in potentiating IL-18 signaling early during MCMV infection.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

IL-12 signaling induces expression of Myd88 in NK cells. (A) qRT-PCR analysis of Myd88 mRNA abundance in NK cells sorted from the spleen of WT mice postinfection with MCMV (n = 4 biological replicates per condition). Fold expression is shown relative to naive mice. (B) qRT-PCR analysis of Myd88 mRNA abundance in WT NK cells stimulated with IL-12 and IL-18 for 18 h (n = 3 biological replicates per condition). Fold expression is shown relative to medium only. (C) Vista browser image of mouse Myd88 promoter showing predicted STAT4 binding site. (D) STAT4 binding at Myd88, Ifng, and control promoters as assessed through ChIP followed by quantitative PCR in sorted WT NK cells stimulated with IL-12 and IL-18 for 18 h. STAT4 occupancy as percent of input is shown for target (Myd88) and control DNA (negative control: average of gene desert 50 kb upstream of Foxp3, Zfp42, and Utf1 promoters; positive control: Ifng promoter). Data were confirmed in two independent experiments. (E) qRT-PCR analysis of Myd88 mRNA abundance in Stat4−/− NK cells relative to WT NK cells from mice infected with MCMV (n = 4 biological replicates per condition). Data are mean ± SEM representative of three independent experiments. *p < 0.05, paired Student t test.

IL-18 signaling is dispensable for recall responses by memory NK cells

To assess whether IL-18 signaling regulates the functional capabilities of memory NK cells, we stimulated WT and Il18r1−/− memory NK cells with Ly49D, Ly49H, or IL-12 and IL-18 and measured their ability to degranulate and to make IFN-γ. Similar to resting NK cells, Il18r1−/− memory NK cells produced less IFN-γ than their WT counterparts only when stimulated with proinflammatory cytokines, but not with Ly49D, Ly49H, or PMA and ionomycin (Fig. 5A and data not shown). Il18r1−/− memory NK cells degranulated similarly to WT (Fig. 5B). Thus, like resting NK cells (5), memory NK cells continue to depend on IL-18 for IL-12–mediated IFN-γ production.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

IL-18 signaling is dispensable for recall response of NK cells. Memory WT and Il18r1−/− NK cells were stimulated with Ly49D, IL-12 and IL-18, or PMA and ionomycin, and percent IFN-γ (A) or CD107a (B) expression is shown. (C) Percentage of recalled WT and Il18r1−/− NK cells (at day 28 PI) are shown after secondary challenge with MCMV. Data are mean ± SEM representative of five independent experiments with at least n = 4 biological replicates per condition. *p < 0.05, paired Student t test. ns, not significant.

Given the importance of IL-18 signaling on the optimal expansion of naive NK cells during MCMV infection, we investigated its role during a recall response. Equal numbers of effector WT and Il18r1−/− NK cells were cotransferred and “parked” in a naive host for 3 wk, followed by infection with MCMV. Surprisingly, Il18r1−/− memory NK cells expanded similarly to their WT counterparts during secondary challenge by MCMV (Fig. 5C), demonstrating a stage-specific requirement for IL-18 signals for proliferation. After the peak of expansion, both cell populations contributed to equal frequencies of secondary memory NK cells. Thus, IL-18 signaling is specifically required for the primary expansion of virus-specific NK cells but is dispensable in the subsequent recall response.

NK cells possess adaptive immune qualities in response to cytokine treatment (14) or exposure to pathogen and nonpathogen Ags (15). It is poorly understood what the cytokine signal requirements are in resting and memory NK cells. In this study, we find a stage-specific requirement for IL-18, where IL-18 promotes the Ag-specific primary expansion of resting NK cells, but not the recall response of memory NK cells. Furthermore, we have identified a previously unknown role for IL-12 in promoting the expression of Myd88 to enhance the IL-18 signaling cascade and possibly sensitize NK cells to lower levels of IL-18 cytokine.

Our current findings suggest that as naive NK cells differentiate into Ag-experienced memory cells, they become “specialized” and may rely more on Ag-specific signals and less on proinflammatory cytokine signals for clonal-like expansion (16). This mechanism would allow previously Ag-experienced NK cells to respond more robustly during subsequent pathogen encounter. Because memory and recall NK cell responses have also been documented in humans post viral infection (1), determining whether a homologous role for IL-18 in the recall response of human NK cells may impact the use of this cytokine in clinical settings.

Disclosures

The authors have no financial conflicts of interest.

Footnotes

  • This work was supported by National Institutes of Health Medical Scientist Training Program Grant T32GM007739 (to S.M.), National Institutes of Health Grant T32AI007621 (to S.M.), National Institutes of Health Grant AI100874 (to J.C.S.), Cancer Research Institute grants (to S.M. and J.C.S.), and the Searle Scholars Program (to J.C.S.).

  • The online version of this article contains supplemental material.

  • Abbreviations used in this article:

    ChIP
    chromatin immunoprecipitation
    For
    forward
    MCMV
    mouse CMV
    PI
    postinfection
    qRT-PCR
    quantitative RT-PCR
    Rev
    reverse
    WT
    wild-type.

  • Received August 11, 2014.
  • Accepted December 10, 2014.
  • Copyright © 2015 by The American Association of Immunologists, Inc.

References

  1. ↵
    Sun, J. C., and L. L. Lanier. 2011. NK cell development, homeostasis and function: parallels with CD8(+) T cells. Nat. Rev. Immunol. 11: 645–657.
  2. ↵
    1. Biron C. A.,
    2. K. B. Nguyen,
    3. G. C. Pien,
    4. L. P. Cousens,
    5. T. P. Salazar-Mather
    . 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189–220.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Sun J. C.,
    2. S. Madera,
    3. N. A. Bezman,
    4. J. N. Beilke,
    5. M. H. Kaplan,
    6. L. L. Lanier
    . 2012. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J. Exp. Med. 209: 947–954.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Beaulieu A. M.,
    2. C. L. Zawislak,
    3. T. Nakayama,
    4. J. C. Sun
    . 2014. The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nat. Immunol. 15: 546–553.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Chaix J.,
    2. M. S. Tessmer,
    3. K. Hoebe,
    4. N. Fuséri,
    5. B. Ryffel,
    6. M. Dalod,
    7. L. Alexopoulou,
    8. B. Beutler,
    9. L. Brossay,
    10. E. Vivier,
    11. T. Walzer
    . 2008. Cutting edge: priming of NK cells by IL-18. J. Immunol. 181: 1627–1631.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Takeda K.,
    2. H. Tsutsui,
    3. T. Yoshimoto,
    4. O. Adachi,
    5. N. Yoshida,
    6. T. Kishimoto,
    7. H. Okamura,
    8. K. Nakanishi,
    9. S. Akira
    . 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383–390.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Pien G. C.,
    2. A. R. Satoskar,
    3. K. Takeda,
    4. S. Akira,
    5. C. A. Biron
    . 2000. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J. Immunol. 165: 4787–4791.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Sun J. C.,
    2. J. N. Beilke,
    3. L. L. Lanier
    . 2009. Adaptive immune features of natural killer cells. Nature 457: 557–561.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Andrews D. M.,
    2. A. A. Scalzo,
    3. W. M. Yokoyama,
    4. M. J. Smyth,
    5. M. A. Degli-Esposti
    . 2003. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4: 175–181.
    OpenUrlCrossRefPubMed
  10. ↵
    1. French A. R.,
    2. H. Sjölin,
    3. S. Kim,
    4. R. Koka,
    5. L. Yang,
    6. D. A. Young,
    7. C. Cerboni,
    8. E. Tomasello,
    9. A. Ma,
    10. E. Vivier,
    11. et al
    . 2006. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J. Immunol. 177: 4981–4990.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Adachi O.,
    2. T. Kawai,
    3. K. Takeda,
    4. M. Matsumoto,
    5. H. Tsutsui,
    6. M. Sakagami,
    7. K. Nakanishi,
    8. S. Akira
    . 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143–150.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Sareneva T.,
    2. I. Julkunen,
    3. S. Matikainen
    . 2000. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J. Immunol. 165: 1933–1938.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Thierfelder W. E.,
    2. J. M. van Deursen,
    3. K. Yamamoto,
    4. R. A. Tripp,
    5. S. R. Sarawar,
    6. R. T. Carson,
    7. M. Y. Sangster,
    8. D. A. Vignali,
    9. P. C. Doherty,
    10. G. C. Grosveld,
    11. J. N. Ihle
    . 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382: 171–174.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Cooper M. A.,
    2. J. M. Elliott,
    3. P. A. Keyel,
    4. L. Yang,
    5. J. A. Carrero,
    6. W. M. Yokoyama
    . 2009. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. USA 106: 1915–1919.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Paust S.,
    2. U. H. von Andrian
    . 2011. Natural killer cell memory. Nat. Immunol. 12: 500–508.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Min-Oo G.,
    2. L. L. Lanier
    . 2014. Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection. J. Exp. Med. 211: 2669–2680.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology: 194 (4)
The Journal of Immunology
Vol. 194, Issue 4
15 Feb 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: Stage-Specific Requirement of IL-18 for Antiviral NK Cell Expansion
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: Stage-Specific Requirement of IL-18 for Antiviral NK Cell Expansion
Sharline Madera, Joseph C. Sun
The Journal of Immunology February 15, 2015, 194 (4) 1408-1412; DOI: 10.4049/jimmunol.1402001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: Stage-Specific Requirement of IL-18 for Antiviral NK Cell Expansion
Sharline Madera, Joseph C. Sun
The Journal of Immunology February 15, 2015, 194 (4) 1408-1412; DOI: 10.4049/jimmunol.1402001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results and Discussion
    • Disclosures
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: Hypoxia-Induced Ubc9 Promoter Hypermethylation Regulates IL-17 Expression in Ulcerative Colitis
  • Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses
  • Cutting Edge: Heterogeneity in Cell Age Contributes to Functional Diversity of NK Cells
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606